Significant reduction in vertebral fracture risk: Evidence for the efficacy of daily and intermittent ibandronate from a large phase III study

$Significant reduction in vertebral fracture risk: Evidence for the efficacy of daily and intermittent ibandronate from a large phase III study$

Journal article

C. Christiansen, C. H. Chesnut, P. D. Delmas, A. Skag, Robert R. Recker, J. A. Stakkestad, A. Hoiseth, D. Felsenberg, J. Gilbride and R. C. Schimmer

Annals of the Rheumatic Diseases, Vol.62, pp.94-95

07/2003

PMID: 12480687

Metrics

4 Record Views

Title: Significant reduction in vertebral fracture risk: Evidence for the efficacy of daily and intermittent ibandronate from a large phase III study
Creators: C. Christiansen (Author)
C. H. Chesnut (Author)
P. D. Delmas (Author)
A. Skag (Author)
Robert R. Recker (Author) - Creighton University
J. A. Stakkestad (Author)
A. Hoiseth (Author)
D. Felsenberg (Author)
J. Gilbride (Author)
R. C. Schimmer (Author)
Publication Details: Annals of the Rheumatic Diseases, Vol.62, pp.94-95
Number of pages: 94-95
Identifiers: 991005931759102656
Academic Unit: School of Medicine; Endocrine
Resource Type: Journal article